The Switzerland-based firm's MosaiQ AiPlex Connective Tissue Diseases (CTDplus) assay is used to aid the diagnosis of autoimmune diseases.

Now, a new study suggests that vivid hallucinations—both during sleep and while awake—could point to an underlying autoimmune disorder. Published in the journal eClinicalMedicine, a recent study found ...

AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) microarray. The MosaiQ ...

Frequent, graphic nightmares aren't just unsettling—they can be your brain’s way of sounding the alarm. In some cases, ...

Anifrolumab can substantially lower the risk for long-term organ damage progression in patients with moderate to severe active lupus, a retrospective study shows.

A risk prediction score that uses machine learning and a patient’s genetic information may identify autoimmune conditions up ...

The US National Institutes of Health defined Mixed Connective Tissue Disease as “a rare autoimmune disorder characterized by ...